Dunbar Geoffrey C

CIK 00012960251 companyWINSTON-SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001296025

Recent Transactions

50 trades

Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-29+55,500→ 55,500 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-20−2,100→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-20$1.75/sh+8,882→ 10,035 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-20$26.02/sh−8,882→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-20−6,782→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-17−2,100→ 2,100 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-17$1.75/sh+2,100→ 3,253 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-17$26.08/sh−2,100→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-16$1.75/sh+200→ 1,353 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-16$25.15/sh−200→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-16−200→ 4,200 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-08−4,896→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-08$5.10/sh+11,250→ 12,403 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-08$22.68/sh−11,250→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-08−6,354→ 0 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-11-05$25.02/sh−700→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-11-05$1.75/sh+700→ 1,853 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-11-05−700→ 4,400 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-11-04−1,271→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-11-04−150→ 5,100 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-11-04$1.75/sh+7,784→ 8,937 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-11-04$25.07/sh−7,784→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-11-04−6,363→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-11-03−986→ 6,363 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-11-03$25.05/sh−986→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-11-03$1.75/sh+986→ 2,139 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-05-13−1,494→ 7,349 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-13$1.75/sh+1,494→ 2,647 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-05-13$25.00/sh−1,494→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-28$1.75/sh+14,700→ 15,853 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-28−14,700→ 8,843 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-28$24.00/sh−14,700→ 1,153 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-27$24.00/sh−200→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-27$1.75/sh+200→ 1,353 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-27−200→ 23,543 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-26$24.00/sh−257→ 1,153 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-04-26−257→ 23,743 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-04-26$1.75/sh+257→ 1,410 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-01-19+50,000→ 50,000 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-12-16$21.86/sh−22,602→ 1,153 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-18$17.19/sh−11,000→ 23,755 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-09-18−11,000→ 6,782 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-18$1.75/sh+11,000→ 34,755 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-16$1.75/sh+9,050→ 32,805 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-09-16−9,050→ 24,000 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-16$16.27/sh−9,050→ 23,755 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-15$16.01/sh−950→ 23,755 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2009-09-15−950→ 33,050 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-15$1.75/sh+950→ 24,705 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2009-09-04$15.02/sh−10,000→ 23,755 total

Companies

GYRE THERAPEUTICS, INC.
VP, Clin. Dev. & Reg. Affairs
$GYRE

Recent Filings

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101

View on SEC.gov